Institut for Biomedicin

Tove Christensen

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark. / Papp, Viktoria; Illés, Zsolt; Magyari, Melinda; Koch-Henriksen, Nils; Kant, Matthias; Pfleger, Claudia Christina; Roemer, Shanu Faerch; Jensen, Michael Broksgaard; Petersen, Annett; Nielsen, Helle Hvilsted; Rosendahl, Lene; Mezei, Z; Christensen, Tove; Svendsen, Kristina Bacher; Jensen, Poul Erik Hyldgaard; Lydolph, Magnus Christian; Heegaard, Niels; Frederiksen, Jette Lautrup; Sellebjerg, F.; Stenager, Egon; Petersen, Thor.

I: Neurology, Bind 91, Nr. 24, 11.12.2018, s. E2265-E2275.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Papp, V, Illés, Z, Magyari, M, Koch-Henriksen, N, Kant, M, Pfleger, CC, Roemer, SF, Jensen, MB, Petersen, A, Nielsen, HH, Rosendahl, L, Mezei, Z, Christensen, T, Svendsen, KB, Jensen, PEH, Lydolph, MC, Heegaard, N, Frederiksen, JL, Sellebjerg, F, Stenager, E & Petersen, T 2018, 'Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.', Neurology, bind 91, nr. 24, s. E2265-E2275. https://doi.org/10.1212/WNL.0000000000006645

APA

Papp, V., Illés, Z., Magyari, M., Koch-Henriksen, N., Kant, M., Pfleger, C. C., Roemer, S. F., Jensen, M. B., Petersen, A., Nielsen, H. H., Rosendahl, L., Mezei, Z., Christensen, T., Svendsen, K. B., Jensen, P. E. H., Lydolph, M. C., Heegaard, N., Frederiksen, J. L., Sellebjerg, F., ... Petersen, T. (2018). Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark. Neurology, 91(24), E2265-E2275. https://doi.org/10.1212/WNL.0000000000006645

CBE

Papp V, Illés Z, Magyari M, Koch-Henriksen N, Kant M, Pfleger CC, Roemer SF, Jensen MB, Petersen A, Nielsen HH, Rosendahl L, Mezei Z, Christensen T, Svendsen KB, Jensen PEH, Lydolph MC, Heegaard N, Frederiksen JL, Sellebjerg F, Stenager E, Petersen T. 2018. Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark. Neurology. 91(24):E2265-E2275. https://doi.org/10.1212/WNL.0000000000006645

MLA

Vancouver

Author

Papp, Viktoria ; Illés, Zsolt ; Magyari, Melinda ; Koch-Henriksen, Nils ; Kant, Matthias ; Pfleger, Claudia Christina ; Roemer, Shanu Faerch ; Jensen, Michael Broksgaard ; Petersen, Annett ; Nielsen, Helle Hvilsted ; Rosendahl, Lene ; Mezei, Z ; Christensen, Tove ; Svendsen, Kristina Bacher ; Jensen, Poul Erik Hyldgaard ; Lydolph, Magnus Christian ; Heegaard, Niels ; Frederiksen, Jette Lautrup ; Sellebjerg, F. ; Stenager, Egon ; Petersen, Thor. / Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark. I: Neurology. 2018 ; Bind 91, Nr. 24. s. E2265-E2275.

Bibtex

@article{fca3d621b6954811883f1975c1c1f397,
title = "Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.",
abstract = "Objectives To estimate the nationwide population-based incidence, prevalence, and geographical distribution of neuromyelitis optica (NMO) spectrum disorder (NMOSD) in Denmark based on the 2015 International Panel for NMO Diagnosis (IPND) criteria. Methods We conducted a multicentre, historically prospective study. Data were sourced from the Danish National Patient Registry, the Danish Multiple Sclerosis Registry, departments of neurology, and laboratories providing aquaporin-4 antibody test. Cases were selected based on the 2006 Wingerchuk and the 2015 IPND criteria and were individually validated by an expert panel. Results We confirmed NMO in 30 cases (2006 criteria) and NMOSD in 56 cases (2015 IPND criteria) between 2007 and 2014. Defined by the 2006 criteria, the incidence of NMO was 0.029 per 100,000 person-years (95% confidence interval [CI] 0.014-0.051), and the prevalence (aged 16 years and older) was 0.566 per 100,000 (95% CI 0.370-0.830). Based on the 2015 IPND criteria, the incidence of NMOSD was 0.070 per 100,000 person-years (95% CI 0.046-0.102), and the prevalence (aged 16 years and older) was 1.09 per 100,000 (95% CI 0.808-1.440), without regional differences. Conclusions Our estimates of incidence and prevalence are similar to other Caucasian population-based studies using the 2015 IPND criteria. We found no geographical clustering in Denmark.",
keywords = "DIAGNOSTIC-CRITERIA, MULTIPLE-SCLEROSIS",
author = "Viktoria Papp and Zsolt Ill{\'e}s and Melinda Magyari and Nils Koch-Henriksen and Matthias Kant and Pfleger, {Claudia Christina} and Roemer, {Shanu Faerch} and Jensen, {Michael Broksgaard} and Annett Petersen and Nielsen, {Helle Hvilsted} and Lene Rosendahl and Z Mezei and Tove Christensen and Svendsen, {Kristina Bacher} and Jensen, {Poul Erik Hyldgaard} and Lydolph, {Magnus Christian} and Niels Heegaard and Frederiksen, {Jette Lautrup} and F. Sellebjerg and Egon Stenager and Thor Petersen",
note = "Copyright {\textcopyright} 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.",
year = "2018",
month = dec,
day = "11",
doi = "10.1212/WNL.0000000000006645",
language = "English",
volume = "91",
pages = "E2265--E2275",
journal = "Neurology",
issn = "0028-3878",
publisher = "LIPPINCOTT WILLIAMS & WILKINS",
number = "24",

}

RIS

TY - JOUR

T1 - Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.

AU - Papp, Viktoria

AU - Illés, Zsolt

AU - Magyari, Melinda

AU - Koch-Henriksen, Nils

AU - Kant, Matthias

AU - Pfleger, Claudia Christina

AU - Roemer, Shanu Faerch

AU - Jensen, Michael Broksgaard

AU - Petersen, Annett

AU - Nielsen, Helle Hvilsted

AU - Rosendahl, Lene

AU - Mezei, Z

AU - Christensen, Tove

AU - Svendsen, Kristina Bacher

AU - Jensen, Poul Erik Hyldgaard

AU - Lydolph, Magnus Christian

AU - Heegaard, Niels

AU - Frederiksen, Jette Lautrup

AU - Sellebjerg, F.

AU - Stenager, Egon

AU - Petersen, Thor

N1 - Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

PY - 2018/12/11

Y1 - 2018/12/11

N2 - Objectives To estimate the nationwide population-based incidence, prevalence, and geographical distribution of neuromyelitis optica (NMO) spectrum disorder (NMOSD) in Denmark based on the 2015 International Panel for NMO Diagnosis (IPND) criteria. Methods We conducted a multicentre, historically prospective study. Data were sourced from the Danish National Patient Registry, the Danish Multiple Sclerosis Registry, departments of neurology, and laboratories providing aquaporin-4 antibody test. Cases were selected based on the 2006 Wingerchuk and the 2015 IPND criteria and were individually validated by an expert panel. Results We confirmed NMO in 30 cases (2006 criteria) and NMOSD in 56 cases (2015 IPND criteria) between 2007 and 2014. Defined by the 2006 criteria, the incidence of NMO was 0.029 per 100,000 person-years (95% confidence interval [CI] 0.014-0.051), and the prevalence (aged 16 years and older) was 0.566 per 100,000 (95% CI 0.370-0.830). Based on the 2015 IPND criteria, the incidence of NMOSD was 0.070 per 100,000 person-years (95% CI 0.046-0.102), and the prevalence (aged 16 years and older) was 1.09 per 100,000 (95% CI 0.808-1.440), without regional differences. Conclusions Our estimates of incidence and prevalence are similar to other Caucasian population-based studies using the 2015 IPND criteria. We found no geographical clustering in Denmark.

AB - Objectives To estimate the nationwide population-based incidence, prevalence, and geographical distribution of neuromyelitis optica (NMO) spectrum disorder (NMOSD) in Denmark based on the 2015 International Panel for NMO Diagnosis (IPND) criteria. Methods We conducted a multicentre, historically prospective study. Data were sourced from the Danish National Patient Registry, the Danish Multiple Sclerosis Registry, departments of neurology, and laboratories providing aquaporin-4 antibody test. Cases were selected based on the 2006 Wingerchuk and the 2015 IPND criteria and were individually validated by an expert panel. Results We confirmed NMO in 30 cases (2006 criteria) and NMOSD in 56 cases (2015 IPND criteria) between 2007 and 2014. Defined by the 2006 criteria, the incidence of NMO was 0.029 per 100,000 person-years (95% confidence interval [CI] 0.014-0.051), and the prevalence (aged 16 years and older) was 0.566 per 100,000 (95% CI 0.370-0.830). Based on the 2015 IPND criteria, the incidence of NMOSD was 0.070 per 100,000 person-years (95% CI 0.046-0.102), and the prevalence (aged 16 years and older) was 1.09 per 100,000 (95% CI 0.808-1.440), without regional differences. Conclusions Our estimates of incidence and prevalence are similar to other Caucasian population-based studies using the 2015 IPND criteria. We found no geographical clustering in Denmark.

KW - DIAGNOSTIC-CRITERIA

KW - MULTIPLE-SCLEROSIS

UR - http://www.scopus.com/inward/record.url?scp=85058607500&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000006645

DO - 10.1212/WNL.0000000000006645

M3 - Journal article

C2 - 30413632

VL - 91

SP - E2265-E2275

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 24

ER -